Buy 3-4-Methylenedioxyamphetamine (MDA) Cas 4764-17-4

3,4-Methylenedioxyamphetamine (MDA) is an entactogen, stimulant, and psychedelic drug of the amphetamine and MDxx families that is encountered mainly as a recreational drug.^[4]^[5]^[6] It is usually taken orally.^[4]^[6]

In terms of its pharmacology, MDA is a serotonin–norepinephrine–dopamine releasing agent (SNDRA) and a serotonin 5-HT₂ receptor agonist, including of the serotonin 5-HT_2A receptor.^[4] It has a duration of 5 to 8 hours or around 6 hours typically.^[4]^[3]^[2]

MDA has a long history of psychotherapeutic and recreational use that predates that of MDMA, dating back to at least the mid-1960s.^[4]^[7]^[5] It has been described as the first entactogen.^[3] MDA has also been described as probably the most popular analogue of MDMA.^[7] In most countries, the drug is a controlled substance and its possession and sale are illegal.

Use and effects

MDA is bought, sold, and used as a recreational drug due to its enhancement of mood and empathy.^[8] It produces MDMA-like effects, including entactogenic and stimulant effects, as well as mild psychedelic effects.^[3]^[9]^[10]^[2]

The dose range of MDA given in Alexander Shulgin‘s book PiHKAL (Phenethylamines I Have Known and Loved) and other sources is 80 to 160 mg.^[6]^[4] A wider recreational dose range for MDA of 20 to 200 mg or more, with a typical dose estimate of 90 mg, has also been reported.^[11] The dose range of MDA is very similar to that of MDMA.^[6]^[4]^[11]^[3]

The effects of MDA include euphoria, empathy, emotional amplification, relaxation, feeling at peace with the world, increased introspection, self-awareness, and acceptance, authenticity, clarity of thought, a desire to communicate with others and relate personal issues, and emotional bonding with others.^[4]^[12]^[13] These effects led to MDA being called the “love drug” or “hug drug”.^[12]^[6] MDA also produces mild psychedelic effects, including brightened colors, closed-eye visuals or complex mental imagery, synaesthesia, and rarely mild hallucinations.^[4]^[3] It does not produce profound sensory disruption or overt hallucinations.^[12]^[13] In any case, the drug has still been found to produce mystical or spiritual experiences.^[9]^[3]

MDA shares most of MDMA’s qualitative and emotional effects, including entactogenic and stimulant effects.^[4]^[13]^[3] However, it has been said to be slightly less stimulating than MDMA.^[4]^[3] Conversely, a clinical study found that it was more stimulating than MDMA.^[2] In addition, MDA’s hallucinogenic effects are much greater than those of MDMA, although still less than those of classical psychedelics like psilocybin.^[4]^[12]^[3]^[2] Another difference between the two drugs is that MDA appears to produce a more introverted and emotionally intense prosocial state, while MDMA encourages a more extroverted and gregarious prosocial state.^[3] MDA produces more negative “bad drug effects” and fear than MDMA.^[2]

Besides its psychoactive effects, MDA produces sympathomimetic effects such as increased heart rate and blood pressure, among other physiological effects.^[7]^[13]^[3]

In terms of the individual enantiomers of MDA, (R)-MDA produces psychedelic effects and some entactogenic effects, while (S)-MDA is non-hallucinogenic, produces similar entactogenic effects as the racemate, and has considerable stimulant effects.^[12]^[13]^[6] High doses of enantiopure (R)-MDA, in the range of 120 to 200 mg, are described as closely resembling the effects of LSD, for instance doses of 200 to 400 μg.^[13]^[14] Enantiopure (R)-MDA at high doses produces more robust psychedelic effects than typical doses of racemic MDA.^[13]^[14]^[6]

3,4-Methylenedioxyamphetamine (CAS 4764-17-4) is a chemical product listed in our expanding product database.

Status: Specifications are under review. For current specifications and industrial procurement inquiries, please contact us directly.

Molecular formula: C10H13NO2

Molecular weight: 179.09

Properties

grade

certified reference material

Quality Segment

300

form

liquid

feature

Snap-N-Spike^®/Snap-N-Shoot^®

packaging

ampule of 1 mL

manufacturer/tradename

Cerilliant^®

drug control

Narcotic Licence Schedule D (Switzerland); psicótropo (Spain); Decreto Lei 15/93: Tabela IIA (Portugal); Pszichotróp anyag / Psychotropic Substance (Hungary), 78/2022. (XII. 28.) BM rendelet, kontrollierte Droge in Deutschland

concentration

1.0 mg/mL in methanol

technique(s)

gas chromatography (GC): suitable, liquid chromatography (LC): suitable

application(s)

forensics and toxicology

format

single component solution

storage temp.

−20°C

SMILES string

NC(C)CC1=CC=C(OCO2)C2=C1

InChI

1S/C10H13NO2/c1-7(11)4-8-2-3-9-10(5-8)13-6-12-9/h2-3,5,7H,4,6,11H2,1H3

InChI key

NGBBVGZWCFBOGO-UHFFFAOYSA-N